How AI is Changing C...
AI Automated Reading...
29th October 2024 Content supplied by: Clever Culture Systems
LBT Announces Bristol Myers Squibb Become First US Pharma Giant to Adopt APAS® Independence
Australian medical technology company LBT Innovations Limited has successfully sold its APAS® Independence instrument to pharmaceutical giant Bristol Myers Squibb in the United States. This landmark sale marks LBT's first foray into the US pharmaceutical market, signaling a significant expansion of its artificial intelligence-driven microbiology automation technology.
The sale, completed within an impressive three-month timeframe, comes as part of Bristol Myers Squibb's ongoing evaluation of the APAS® Independence, which began in the September 2024 quarter. This rapid progression from evaluation to purchase underscores the compelling value proposition of LBT's cutting-edge technology in the pharmaceutical industry.
Tags:
Date Published: 29th October 2024
Source article link: View
How AI is Changing Compliance
AI Automated Reading of Environmental